Uwe Schoenbeck (L) and Julie Grant
Canaan adds $100M+ to boost biopharma investing, brings on former Pfizer exec
Canaan, a decades-old tech and life sciences venture capital firm, plans to invest more heavily in biopharma going forward.
The Menlo Park, CA-based firm added …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
